10:43     CKLIFE SCIENCES<08222> - Announcement (2)                           

    seek the approval of the Independent Shareholders in                      
    relation to the New CKH Continuing Connected Transactions                 
    and the New HIL Continuing Connected Transactions                         
    respectively.  It is proposed that ordinary resolutions                   
    will be proposed at the forthcoming AGM of the Company                    
    for the Independent Shareholders to approve by way of poll                
    the New CKH Continuing Connected Transactions and the New                 
    HIL Continuing Connected Transactions respectively and                    
    the respective annual caps which the transactions shall                   
    not exceed.  CKH, HIL and their respective associates will                
    be required to abstain from voting on the ordinary                        
    resolutions to approve the New CKH Continuing Connected                   
    Transactions and the New HIL Continuing Connected                         
    Transactions respectively.                                                
                                                                              
    A circular containing, among other things, (1) further                    
    information on the New Continuing Connected Transactions;                 
    (2) the recommendation of the Independent Board Committee                 
    to the Independent Shareholders; (3) the advice from an                   
    independent financial adviser to the Independent Board                    
    Committee and the Independent Shareholders; and (4) a                     
    notice of the AGM including ordinary resolutions to be                    
    proposed to approve the New CKH Continuing Connected                      
    Transactions and the New HIL Continuing Connected                         
    Transactions respectively will be despatched to the                       
    Shareholders as soon as practicable.                                      
                                                                              
    By Order of the Board                                                     
    CK Life Sciences Int'l., (Holdings) Inc.                                  
    Eirene Yeung                                                              
    Company Secretary                                                         
                                                                              
    Hong Kong, 29 March 2005                                                  
                                                                              
    As at the date of this announcement, the Executive                        
    Directors of the Company are Mr. Li Tzar Kuoi, Victor                     
    (Chairman), Mr. Kam Hing Lam, Mr. Ip Tak Chuen, Edmond,                   
    Mr. Yu Ying Choi, Alan Abel, Dr. Pang Shiu Fun, Dr. Chu                   
    Kee Hung and Mr. Lam Hing Chau, Leon; and the Non-executive               
    Directors are Mr. Kwan Chiu Yin, Robert (Independent                      
    Non-executive Director), Mr. Peter Peace Tulloch,                         
    Professor Wong Yue-chim, Richard (Independent                             
    Non-executive Director), Mrs. Kwok Eva Lee (Independent                   
    Non-executive Director) and Mr. Colin Stevens Russel                      
    (Independent Non-executive Director).                                     
                                                                              
    This announcement, for which the Directors collectively                   
    and individually accept full responsibility, includes                     
    particulars given in compliance with the GEM Listing Rules                
    for the purpose of giving information with regard to the                  
    Company. The Directors, having made all reasonable                        
    enquiries, confirm that, to the best of their knowledge                   
    and belief: (i) the information contained in this                         
    announcement is accurate and complete in all material                     
    respects and not misleading; (ii) there are no other                      
    matters the omission of which would make any statement                    
    in this announcement misleading; and (iii) all opinions                   
    expressed in this announcement have been arrived at after                 
    due and careful consideration and are founded on bases                    
    and assumptions that are fair and reasonable.                             
                                                                              
    This announcement will remain on the "Latest Company                      
    Announcements" page of the GEM website at www.hkgem.com                   
    for at least 7 days from the date of its posting and on                   
    the website of the Company at www.ck-lifesciences.com.                    
                                                                              
    The above announcement is a summary only. For the full                    
    version of this announcement, please refer to the `Latest                 
    Company Announcements' page on the GEM website at www.hkgem.com.